Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202546

Expand all

RIBAVIRIN (RIBAVIRIN)
200MG
Marketing Status: Discontinued

Active Ingredient: RIBAVIRIN
Proprietary Name: RIBAVIRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202546
Product Number: 001
Approval Date: Aug 12, 2014
Applicant Holder Full Name: BEXIMCO PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

RIBAVIRIN (RIBAVIRIN)
400MG
Marketing Status: Discontinued

Active Ingredient: RIBAVIRIN
Proprietary Name: RIBAVIRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202546
Product Number: 002
Approval Date: Aug 12, 2014
Applicant Holder Full Name: BEXIMCO PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

RIBAVIRIN (RIBAVIRIN)
500MG
Marketing Status: Discontinued

Active Ingredient: RIBAVIRIN
Proprietary Name: RIBAVIRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202546
Product Number: 003
Approval Date: Aug 12, 2014
Applicant Holder Full Name: BEXIMCO PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

RIBAVIRIN (RIBAVIRIN)
600MG
Marketing Status: Discontinued

Active Ingredient: RIBAVIRIN
Proprietary Name: RIBAVIRIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 600MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202546
Product Number: 004
Approval Date: Aug 12, 2014
Applicant Holder Full Name: BEXIMCO PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information